SynthesisNeurology2008

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

D M Simpson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.